In this recorded panel discussion, members of different healthcare organizations discuss the potential impact of the FDA Rule on LDTs, near term / long term implications, and stakeholder’s priorities for minimal disruption. By watching this panel...
Read More2 min read
Extending Patient Lifespan with LifeSTEM What is Glioblastoma? Gliomas are brain tumors that come in multiple forms ranging from low-grade, benign...
3 min read
Accelerate Your Product Development Timeline One of the biggest timeline impacts in any development program is getting the product to work. Our...
In this white paper, our regulatory team presents the frameworks governing Laboratory Developed Tests in Europe and the USA, and discuss important...
Let’s Connect at Outsourcing in Clinical Trials West Coast! February 11–12, 2025 | Booth 61 Burlingame, CA Meet with Our Team at Outsourcing in...
2 min read
How Clinical Teams Are Replacing Firefighting With Future-Proof Monitoring The Silent Efficiency Leak: Why Legacy Systems Fail In 2024, a study of...
Let’s Connect at SCOPE Summit 2025! February 4–5, 2025 | Booth 620 Orlando, Florida Meet with Our Team at SCOPE Summit Danita Harris SVP Clinical...
2 min read
Maria Artunduaga, MD, MPH, MTM Founder and CEO of Samay In This Podcast: How and why Dr. Artunduaga created her company The challenges she faced...
2 min read
26th November | 14:00 – 18:00 | Medicon Village, Lund, Sweden Free of Charge Are you an IVD professional looking to gain insights into the current...
3 min read
The integration of artificial intelligence into medical devices represents a transformative shift in healthcare technology. Yet, for manufacturers...
